Placental Stem Cell Hepatocyte Differentiation via Sodium Butyrate
Solution Overview
Problem
There is a lack of an ethically acceptable source for autologous stem cells that can differentiate into hepatocytes, which is crucial for treating liver disorders, and existing methods for stem cell differentiation into hepatocytes are inefficient.
Innovation Solution
The production of hepatocytes from adherent placental stem cells using specific culturing conditions, such as sodium butyrate treatment and encapsulation in alginate-poly-L-lysine, and their use in treating liver-related diseases, including cirrhosis and viral hepatitis, along with the use of nanofibrous scaffolds for cartilage repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If embryonic stem cells are used for hepatocyte differentiation, then hepatocyte production is achieved, but ethical acceptability is compromised
Solution Approach 1:
The patent extracts the desired hepatocyte differentiation capability from embryonic stem cells and transfers it to placental stem cells, which provide the same functional benefit without the ethical controversies associated with embryonic stem cell sources
Solution Approach 2:
The patent creates a copy of the hepatocyte differentiation pathway by using placental stem cells that can be directed to differentiate into hepatocytes through specific culture conditions, effectively replicating the therapeutic benefit of embryonic stem cells without using them
2Productivity
If conventional stem cell differentiation methods are used, then hepatocyte production is achieved, but differentiation efficiency is low
Solution Approach 1:
The patent employs parameter changes by modifying culture conditions including specific growth factors, serum concentrations, and chemical agents to direct placental stem cell differentiation toward the hepatocyte lineage with high efficiency
Solution Approach 2:
The patent uses intermediary substances such as growth factors and chemical agents in the culture medium that mediate the differentiation process, guiding placental stem cells to become hepatocytes through controlled biochemical signals
Data Source
AI summary
Provided herein are methods and compositions for the production of hepatocytes from placenta stem cells. Further provided herein is the use of such hepatocytes in the treatment of, and intervention in, for example, trauma, inflammation, and degenerative disorders of the liver. Also provided herein are compositions and methods relating to combinations of nanofibrous scaffolds and adherent placental stem cells and methods of using the same in cartilage repair. Finally, provided herein are compositions and methods relating to nonadherent, CD34+CD45− stem cells from placenta.



